Total Uterine Sampling

Publisher Website
Google Scholar
Abstract
MOST gynecologists agree that early cervical cancer is rarely visualized in clinical practice. The early phase in the history of the disease is preclinical. The vaginal smear has presented abundant evidence of this concept. Papanicolaou,1 , 2 Meigs,3 Jones4 and others have reported cancer cells in vaginal secretions in women whose cervixes appeared clinically normal. Traut5 has insisted, with good reason, that the vaginal smear represents the most valuable clinical test in the armamentarium of the gynecologist. Few gynecologists order vaginal smears on patients whose cervixes look normal, and yet the most important positive findings come from this group. Ayre6 has pointed . . .

This publication has 11 references indexed in Scilit: